More tools:Markets·Screener·Research·Chat

Ionis Pharmaceuticals, Inc. Common Stock (IONS) Financial Statements

Ionis Pharmaceuticals, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SB7RD1
XNAS · usd
56.71▼ 1.38 (-2.38%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close58.09
Day's Range52.15 – 57.43
52-Week Range50.01 – 86.74
Volume9.1M
Avg Volume2.6M
Share Statistics
Shares Outstanding
Employees1,402
ExchangeXNAS
Listed1991-05-17
Share count as of July 23, 2026
Loading Income Statement…
Key questions about Ionis Pharmaceuticals, Inc. Common Stock (IONS)
What is Ionis Pharmaceuticals, Inc. Common Stock's Market Cap?
Ionis Pharmaceuticals, Inc. Common Stock's Market Cap is $9.4B, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's Enterprise Value?
Ionis Pharmaceuticals, Inc. Common Stock's Enterprise Value is $9.1B, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's Price / Sales?
Ionis Pharmaceuticals, Inc. Common Stock's Price / Sales is 10.8×, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's EV / Revenue?
Ionis Pharmaceuticals, Inc. Common Stock's EV / Revenue is 10.4×, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's EV / EBITDA?
Ionis Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?
Ionis Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $874.1M, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?
Ionis Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$565.2M, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's EBITDA?
Ionis Pharmaceuticals, Inc. Common Stock's EBITDA is -$579.5M, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?
Ionis Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -3.40, based on as-reported figures from SEC (XBRL) filings.
What is Ionis Pharmaceuticals, Inc. Common Stock's EBITDA Margin?
Ionis Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -66.3%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Revenue
YoY growth-40.7%+87.0%-10.3%+17.1%
Expenses:
Cost of sales
Research, development and patent
Selling, general and administrative
Total operating expenses
% of revenue138.2%147.7%205.5%202.2%
Income (loss) from operations
% of revenue-38.2%-47.7%-105.5%-102.2%
Other income (expense):
Investment income
Interest expense
Interest expense related to sale of future royalties
Gain (loss) on investments, net
Other income, net
Income (loss) before income tax benefit (expense)
Income tax benefit (expense)
Net income (loss)
% of revenue-42.8%-37.6%-112.8%-82.1%
Basic net income (loss) per share (in Dollars per share)
Diluted net income (loss) per share (in Dollars per share)